European drug regulator backs mixing of COVID-19 vaccines – Community News
Covid-19

European drug regulator backs mixing of COVID-19 vaccines

Posted:
Updated:

Pedestrians wear masks to prevent the spread of COVID-19 as they pass a shop decorated as part of Christmas lights, in Paris, Monday, December 6, 2021. The new potentially more contagious ommicron variant of the coronavirus has appeared in more European countries just days after being identified in South Africa, governments around the world scrambled to stop the spread. (AP Photo/Christophe Ena)

THE HAGUE, Netherlands (AP) – The European Union’s drug regulator on Tuesday supported mixing different types of vaccines in initial vaccination and booster campaigns to fight the coronavirus.

The European Medicines Agency said in a statement that using different types of vaccines together, known as heterologous vaccination, can protect against COVID-19.

The announcement comes as much of Europe faces rising infection and hospitalization rates and concerns about the new ommicron variant.

The EMA, along with the European Center for Disease Control, said a mix-and-match strategy could give countries more options in vaccination campaigns, as much of the continent faces rising infection and hospitalization rates.

“The evidence to date with different types of authorized vaccines indicates that a heterologous booster appears to be as good or better in terms of immune responses than a homologous booster,” the agencies said in a statement.